Kane Investment Management, Inc. Vertex Pharmaceuticals Inc Transaction History
Kane Investment Management, Inc.
- $191 Billion
- Q2 2025
A detailed history of Kane Investment Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Kane Investment Management, Inc. holds 2,231 shares of VRTX stock, worth $908,842. This represents 0.52% of its overall portfolio holdings.
Number of Shares
2,231
Previous 2,320
3.84%
Holding current value
$908,842
Previous $1.12 Billion
11.69%
% of portfolio
0.52%
Previous 0.54%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,796Shares Held
239MCall Options Held
1.95MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$11.7 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$9.77 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.68 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.56 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.8 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $105B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...